KACTUS

KACTUS operates as a critical supplier of research tools and reagents in the biotech ecosystem, providing high-quality recombinant proteins, enzymes, and assay kits. Its business model combines a large catalog of off-the-shelf products with custom protein expression and analysis services, targeting applications in antibody discovery, cell therapy, and gene editing. The company emphasizes in-house production, rigorous quality control, and rapid distribution from its Boston inventory center. While private and likely generating early revenue from product sales, KACTUS positions itself as an enabler for therapeutic developers rather than a drug developer itself.

SAMS™ Technology Platform for tailored protein expression, utilizing multiple expression systems, VLP/Nanodisc display for membrane proteins, and rigorous QC for high-purity, bioactive recombinant proteins and GMP enzymes.

Competes in the fragmented life science reagents market against giants like Thermo Fisher Scientific and Abcam, as well as specialized recombinant protein firms (e.g., ACROBiosystems, Sino Biological). Differentiation is based on niche expertise in difficult-to-express proteins (membrane proteins, complexes), GMP production of enzymes, and rapid delivery of catalog items.